On this page
More than one procedural pathway
Procedures may be discussed when medical control is inadequate, adverse effects are difficult to tolerate, or other clinical considerations change the care plan. MVD is one option. Percutaneous procedures and stereotactic radiosurgery offer different approaches, which may be relevant to people who cannot or prefer not to undergo cranial surgery. An informed discussion considers their benefits and burdens together.1
“Less invasive” describes part of a procedure's burden; it does not mean the procedure is risk-free or appropriate for every person. Ask which diagnosis, subtype and previous-procedure history the recommendation addresses. A general article cannot rank options for an individual or establish that the associated practice offers each one.
Percutaneous techniques
Percutaneous treatment reaches the trigeminal region through a needle or thin tube introduced through the cheek, with imaging guidance. Balloon compression uses controlled mechanical compression; radiofrequency thermocoagulation uses heat; glycerol rhizolysis uses a chemical approach. These procedures alter nerve signalling through a lesion rather than separating a compressing vessel from the nerve.2
The word “rhizotomy” can appear in discussions of these approaches. Clarify which technique is intended rather than assuming all procedures described by that word have identical effects. Details of anaesthesia, treatment setting and selection belong to the service providing the procedure.
Sensory changes are a real tradeoff
Facial sensory change is common after neuroablative techniques. Numbness may be persistent, and some people develop troublesome altered sensation. RCS also describes the uncommon but serious possibility of painful numbness, called anaesthesia dolorosa, and eye-related concerns if protective sensation or reflexes are affected. These risks need discussion before treatment, not dismissal because the access incision is smaller.3
Ask how the team defines relief, which sensory changes are expected and which require reassessment. Ask how evidence separates initial procedures from repeated treatment and how long patients were followed. Recurrence is possible, but a single generic success percentage cannot compare all techniques fairly.
Stereotactic radiosurgery
Radiosurgery delivers focused radiation to the trigeminal nerve. Gamma Knife and other platform names refer to ways of delivering stereotactic treatment; they are not separate TN diagnoses. Pain relief may develop after a delay, and sensory changes can also occur. There is no open decompression of a vessel during radiosurgery.2
RCS emphasizes that radiosurgery's delayed effect makes it unsuitable as immediate treatment of an acute pain crisis. It describes numbness and other sensory risks and distinguishes treatment after a prior intervention from first treatment. A repeat-radiosurgery discussion therefore needs its own exposure and risk assessment.3
Compare the right evidence
EAN found limited evidence for choosing among neuroablative approaches. The newer Fonseca network meta-analysis reports low to very low certainty and draws mainly on observational studies. Such comparisons are affected by who received each treatment; indirect rankings are not a personal treatment recommendation.14
For consent, ask about the expected timing of benefit, ongoing medication plan, sensory tradeoffs, possibility of returning pain and what another intervention would involve. Record whether the discussion concerns stand-alone treatment or a combination with decompression. Your priorities and the treating team's assessment remain central.
References
- Bendtsen L et al. European Academy of Neurology guideline. Eur J Neurol. 2019;26:831–849. Source ↩
- NHS. Trigeminal neuralgia: treatment. Source ↩
- McMillan R et al. Guidelines for the management of trigeminal neuralgia. RCS England Faculty of Dental Surgery, 2021. Source ↩
- Fonseca PEO et al. From MVD to radiosurgery: network meta-analysis. Neurosurg Rev. 2026;49:261. PMID 41793527. PubMed ↩